EmbectaEMBC -0.45%53 Net Debt Paydown Yield % is 86.62% as of Jul. 06, 2026, which is 5957% above its 10-year median of 1.43. GuruFocus rates EMBC with a GF Score™ of 53/100 and a GF Value™ of $12.68 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 773 Medical Devices & Instruments companies, Embecta ranks better than 99.09% on this metric.
Net Debt Paydown Yield % is a metric that evaluates the total amount of debt a company has paid in relation to its market capitalization. It is a measure of a company's willingness and ability to reduce its debt.
As of today, Embecta's Net Debt Paydown Yield % was 86.62%.
Embecta (NAS:EMBC) Net Debt Paydown Yield % Explanation
Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced. In other words, it is a measure of the willingness and ability of a firm's management to pay down debt. Companies that have high debt paydown yields indicate that they are more aggressive with paying down debt.
In the calculation of Net Debt Paydown Yield %, we use the reductions of TTM average total debt one-year-ago and TTM average total debt at present, divided by its Market Cap.
The historical data trend for Embecta's Net Debt Paydown Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EMBC vs KRMD, SMTI, PDEX: Net Debt Paydown Yield % Comparison
For the Medical Instruments & Supplies subindustry, Embecta's Net Debt Paydown Yield %, along with its competitors' market caps and Net Debt Paydown Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Embecta Net Debt Paydown Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Embecta's Net Debt Paydown Yield % distribution charts can be found below:
* The bar in red indicates where Embecta's Net Debt Paydown Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Net Debt Paydown Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.
What does a Net Debt Paydown Yield % of 86.62% mean?
Embecta (EMBC) has a Net Debt Paydown Yield % of 86.62% as of Jul. 06, 2026. Net Debt Paydown Yield is a metric that evaluates the total amount of debt a company has paid in relation to its market capitalization. This metric provides insight into a company's willingness and ability to reduce its debt using free cash flow. View historical data on Embecta and its competitors. This is 5957% above median its historical median of 1.43. According to the industry distribution chart, Embecta ranks #7 out of 773 companies in the Medical Devices & Instruments industry, placing it in the top 0.90000000000001%.
Is Embecta's Net Debt Paydown Yield % too high?
Embecta's current Net Debt Paydown Yield % of 86.62% is 5957% above median its 10-year median of 1.43. The Medical Devices & Instruments industry median Net Debt Paydown Yield % is 0.01. Embecta's value of 86.62% is 866100% above this industry median. Based on the distribution chart, Embecta ranks #7 out of 773 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Embecta has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Embecta's Net Debt Paydown Yield % compare to KRMD and SMTI?
According to the Medical Devices & Instruments industry distribution chart, Embecta ranks #7 out of 773 companies for Net Debt Paydown Yield %. This places Embecta in the top 1% of its industry — outperforming the majority of peers. The industry median Net Debt Paydown Yield % is 0.01. Embecta's value of 86.62% is 866100% above this benchmark. While the company's 10-year median is 1.43 vs. the industry median of 0.01, Embecta has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Debt Paydown Yield % for a Medical Devices & Instruments company?
The median Net Debt Paydown Yield % among Medical Devices & Instruments companies is 0.01, based on 773 companies in the industry. Companies in the top quartile (top 25%) have a Net Debt Paydown Yield % significantly above this median, while those in the bottom quartile fall well below. However, Net Debt Paydown Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Embecta's current Net Debt Paydown Yield % of 86.62% is 866100% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Debt Paydown Yield % mean?
A high Net Debt Paydown Yield % can signal that a stock is expensive relative to its fundamentals. Net Debt Paydown Yield is a metric that evaluates the total amount of debt a company has paid in relation to its market capitalization. This metric provides insight into a company's willingness and ability to reduce its debt using free cash flow. View historical data on Embecta and its competitors. For the Medical Devices & Instruments industry, the median Net Debt Paydown Yield % is 0.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Embecta's current Net Debt Paydown Yield % is 86.62%, which is 5957% above median its own 10-year median of 1.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Embecta stock overvalued right now?
Based on GuruFocus' analysis, Embecta (EMBC) is currently considered Possible Value Trap. The stock's GF Value™ is $12.68, compared to a current price of $3.35 — trading 73.6% below its estimated fair value. The current Net Debt Paydown Yield % is 86.62%, which is 5957% above median its 10-year median of 1.43 and 866100% above the Medical Devices & Instruments industry median of 0.01. Embecta's overall GF Score™ is 53/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Debt Paydown Yield % calculated?
Net Debt Paydown Yield % is calculated from a company's financial statements. For Embecta (EMBC), the current Net Debt Paydown Yield % is 86.62% as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Embecta (EMBC) Overvalued in 2026?
Based on GuruFocus' analysis, Embecta stock appears to be undervalued.
The current stock price of $3.35 is trading 73.6% below its estimated GF Value™ of $12.68.
GuruFocus considers Embecta to be Possible Value Trap.
Key valuation signals for EMBC:
Net Debt Paydown Yield %: 86.62% (5957% above median its 10-year median of 1.43)
GF Value™: $12.68 vs. price of $3.35 (73.6% below fair value)
Industry Position: 866100% above the Medical Devices & Instruments median (#7 of 773)
No single metric tells the full story. See the EMBC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
53GF Score
Get the complete analysis for EMBC
Net Debt Paydown Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EMBC has been successfully added to your 
